Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

TG103

A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes

CSPC Baike (Shandong) Biopharmaceutical Co · Phase 2 · Status n/r · Enrollment 208

NCT05063253

ArmPopulationDoseWeeksEstimandWeight change
TG103, 15 mgT2D only15 mgn/rn/rn/r
TG103, 22.5 mgT2D only22.5 mgn/rn/rn/r
TG103, 30 mgT2D only30 mgn/rn/rn/r
PlaceboT2D onlyn/rn/rn/rn/r